RETRACTION: Oleuropein Improves Cognitive Dysfunction and Neuroinflammation in Diabetic Rats through the PI3K/Akt/mTOR Pathway (Retraction of Vol 2022, art no 5892463, 2022)

被引：0
|
作者：
Shang, J.
Che, S.
Zhu, M.
机构：
来源：
APPLIED BIONICS AND BIOMECHANICS | 2023年 / 2023卷
关键词：
D O I：
10.1155/2023/9813730
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RETRACTED: Oleuropein Improves Cognitive Dysfunction and Neuroinflammation in Diabetic Rats through the PI3K/Akt/mTOR Pathway (Retracted Article)
    Shang, Jianru
    Che, Shan
    Zhu, Mingjie
    APPLIED BIONICS AND BIOMECHANICS, 2022, 2022
  • [2] RETRACTION: Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway (Retraction of Vol 2022, art no 9687345, 2022)
    Ren, M.
    Pan, D.
    Zha, D.
    Shan, Z.
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [3] RETRACTION: A Study on Curcumol Influencing Proliferation and Apoptosis of Hepatocellular Carcinoma Cells through DJ-1/PTEN/PI3K/AKT Pathway (Retraction of Vol 2022, art no 9912776, 2022)
    Zhang, R.
    Zhong, L.
    Sun, K.
    BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [4] RETRACTION: Kuntai capsule attenuates premature ovarian failure through the PI3K/AKT/mTOR pathway (Retraction of Vol 239, art no 111885, 2019)
    Zhang, Han
    Qin, Fenfen
    Liu, Anlong
    Sun, Qinmei
    Wang, Qisheng
    Li, Qian
    Lu, Shengfeng
    Zhang, Dong
    Lu, Zhigang
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 289
  • [5] RETRACTION: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours (Retraction of Vol 10, art no 54, 2020)
    Xu, Fei
    Na, Lixin
    Li, Yanfei
    Chen, Linjun
    CELL AND BIOSCIENCE, 2021, 11 (01):
  • [6] RETRACTION: TJZYF Improves Endometrial Receptivity through Regulating VEGF and PI3K/AKT Signaling Pathway
    You, F.
    Du, X.
    Zhang, T.
    Wang, Y.
    Lv, Y.
    Zeng, L.
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [7] RETRACTION: Effect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway (Retraction of Vol 23, Pg 10549, 2019)
    Wang, Y. -Y.
    Cheng, X. -D.
    Jiang, H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (17) : 7881 - 7881
  • [8] RETRACTION: Rapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting SIRT1 in esophageal cancer (Retraction of Vol 22, art no 1190, 2021)
    Liu, Tao
    Liang, Xiangsen
    Sun, Yu
    Yang, Shengzhuang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (01)
  • [9] RETRACTION: Two photoluminescent Zn(II) complexes: protection evaluation against cancer disease by reducing activation of PI3K/Akt signaling pathway (Retraction of Vol 1256, art no 132484, 2022)
    Gu, Xiao-Yi
    Bai, Ri-Lan
    Cui, Jiu-Wei
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1277
  • [10] RETRACTION: PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas (Retraction of Vol 13, art no 18, 2024)
    Yoon, Changhwan
    Lu, Jun
    Yi, Brendan C.
    Chang, Kevin K.
    Simon, M. Celeste
    Ryeom, Sandra
    Yoon, Sam S.
    ONCOGENESIS, 2024, 13 (01):
12345